ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Centers for Medicare & Medicaid Services . Conditions for Coverage for End-Stage Renal Disease Facilities; Final Rule. www.cms.hhs.gov/CFCsAndCoPs/downloads/ESRDfinalrule0415.pdf. Apr. 15, 2008: p 74. Accessed Nov. 10, 2010.
-
2.
U.S. Food and Drug Administration . Information for Healthcare Professionals: Erythropoiesis Stimulating Agents (ESA) [Aranesp (darbepoetin), Epogen (epoetin alfa), and Procrit (epoetin alfa)]. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatients&Providers/ucm126481.htm. (Page last updated Sep. 29, 2010). Accessed Nov. 24, 2010.
-
3.
Centers for Medicare & Medicaid Services . Conditions for Coverage for End-Stage Renal Disease Facilities; Final Rule. www.cms.hhs.gov/CFCsAndCoPs/downloads/ESRDfinalrule0415.pdf. Apr. 15, 2008: p 74. Accessed Nov. 10, 2010.
CROWNWeb’s ESRD Clinical Performance Measures Data to Be in Place by Mid-2011
Oniel Delva
Oniel Delva
Search for other papers by Oniel Delva in
Current site
Google Scholar
PubMed
Search for other papers by Oniel Delva in
Current site
Google Scholar
PubMed
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory
Powered by PubFactory